Dimensional Fund Advisors LP Chimerix Inc Transaction History

Dimensional Fund Advisors LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$1.19 - $2.09 $371,152 - $651,856	-311,893 Reduced 66.51%	157,050 $197,000
Q4 2022 Feb 09, 2023	SELL	$1.67 - $2.35 $256,119 - $360,407	-153,365 Reduced 24.64%	468,943 $872,000
Q3 2022 Nov 10, 2022	SELL	$1.81 - $2.76 $1.21 Million - $1.85 Million	-670,252 Reduced 51.85%	622,308 $1.2 Million
Q2 2022 Aug 12, 2022	SELL	$1.34 - $5.34 $883,007 - $3.52 Million	-658,961 Reduced 33.77%	1,292,560 $2.69 Million
Q1 2022 May 13, 2022	BUY	$4.58 - $6.8 $948,014 - $1.41 Million	206,990 Added 11.87%	1,951,521 $8.94 Million
Q4 2021 Feb 09, 2022	SELL	$5.23 - $7.18 $554,353 - $761,044	-105,995 Reduced 5.73%	1,744,531 $11.2 Million
Q3 2021 Nov 12, 2021	SELL	$5.94 - $8.75 $2.42 Million - $3.57 Million	-407,873 Reduced 18.06%	1,850,526 $11.5 Million
Q2 2021 Aug 12, 2021	BUY	$7.54 - $9.79 $711,052 - $923,236	94,304 Added 4.36%	2,258,399 $18.1 Million
Q1 2021 May 14, 2021	SELL	$4.76 - $11.25 $520,215 - $1.23 Million	-109,289 Reduced 4.81%	2,164,095 $20.9 Million
Q4 2020 Feb 25, 2021	BUY	$2.43 - $5.42 $5.52 Million - $12.3 Million	2,273,384 New	2,273,384 $11 Million

37M

52.7K

130K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $77.1M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.